Morrisville, North Carolina – September 22, 2022 – Alcami, a U.S.-based pharmaceutical contract development and manufacturing organization (CDMO), announced today the addition of a 12,000 ft² solid-state characterization laboratory. The dedicated solid-state research and development suite is co-located within Alcami's existing Morrisville laboratory and part of Alcami's growing 675,000 ft² of integrated operations.
Wilmington, N.C. – May 3, 2022 – Alcami, a leading United States-based contract development and...
With today’s growing pipeline of biologics, namely complex oncology products often delivered...
Morrisville, North...
As a proud member of the Drug, Chemical & Associated Technologies Association, Alcami is pleased to...
An increasing number of clinical trial registrations, more R&D investment, growing demand for...
Read this case study to learn how Alcami supported Carolina Components Group in the successful...
DURHAM, N.C. – November 16, 2021 – Alcami, a leading United States-based contract development and...
DURHAM, N.C. – October 12, 2021 - Alcami, a leading United States-based contract development and...
CHARLESTON, S.C. – September 29, 2021 - Alcami, a leading United States-based contract development...
Recently, contract development and manufacturing organizations (CDMOs) involved in the...
Client Profile
The client needed formulation development of an oral dosage form from scratch. They...
As opposed to traditional drug production, the production of biological products (biologics)...
According to the Food and Drug Administration and the Orphan Drug Designation program, orphan...
The agreement represents another step toward the proprietary manufacturing, formulation, and...
Combination products are becoming increasingly important to pharmaceutical CDMOs like Alcami, said...
From standalone projects through full-service programs, our laboratories provide solutions to your...
Wilmington, N.C. – March 18, 2021 – Alcami, a global pharmaceutical contract development and...
You're invited to take part in a now on demand webinar. During this webinar, regulatory and quality...
The global pharmaceutical analytical testing outsourcing market was estimated at $6.1 billion in...
Alcami, a leading United States-based contract development and manufacturing organization...
Although there is no such thing as a truly “crisis-proof” organization, how are you working to...
Today’s technology has not only changed the way we receive information, but has continually adapted...
A holistic approach to validation and quality assurance is essential.
Biologic drugs are highly...
You're invited to attend our on demand virtual event. During this webinar, scientific experts will ...
Global contract development and manufacturing organisation (CDMO), Sterling Pharma...
We're kicking off the opening of our new formulation and sterile fill-finish facility with a...
Alcami’s scientists have substantial experience designing and executing food interaction studies...
MORRISVILLE, N.C., July 28, 2020 -- Alcami, a US-based contract development and manufacturing...
In recent years 505(b)(2) approvals have experienced double-digit growth. Many companies are...
Increasing prevalence of drug misuse and abuse is driving a heightened and more stringent approach...
WILMINGTON, NC – May 21, 2020 – Alcami, a North Carolina-based contract development and...
WILMINGTON, NC – MAY 18, 2020 – Alcami, a North Carolina-based contract development and...
As a contract manufacturer, Alcami provides experience in all aspects of the manufacturing process,...
Signed into law on January 4, 1983, the Orphan Drug Act (ODA) allows for granting special status to...
WOODCLIFF LAKE, N.J. —April 16, 2020— Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”), a New...
Even well-designed product formulations can fail if it is contained in inappropriate packaging. How...
Alcami’s end-to-end analytical testing platform supports clients’ programs through every stage of a
A Full-Time Equivalent (FTE) agreement is a comprehensive analytical service that grants...
Transaction Advances Alcami’s Strategic Plan by Adding Scale in Attractive and Growing Parenteral...
Name: Katie Shupe
Alcami Site: St. Louis, MO
What is your role?
I am a lead chemistry analyst. I...
